Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07341139 · ClinicalTrials.gov registry record
Blood Storage Related Mortality and Adverse Effects in Trauma Patients
A clinical trial of Transfusion Adverse Reaction and Major Trauma, sponsored by Kocaeli City Hospital.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT07341139: Recruiting study of Transfusion Adverse Reaction and Major Trauma, sponsored by Kocaeli City Hospital.
NCT07341139 is a study of Transfusion Adverse Reaction and Major Trauma that is actively recruiting participants, run by Kocaeli City Hospital. The registered enrollment target is 300 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07341139, a study of Transfusion Adverse Reaction and Major Trauma, is actively recruiting participants, sponsored by Kocaeli City Hospital.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this retrospective study is to examine the following factors related to blood storage time in severely injured trauma patients who received large blood transfusions: 1. The effect of blood storage time on the patient's 28-day mortality rate. 2. The relationship between storage time and other health problems that the patient may develop (such as heart disease, vascular occlusion, respiratory failure, infection, and organ failure). For this purpose, patients aged 18-75 who were admitted directly from the scene of injury and received large transfusions at Jacksonville Shands Hospital between January 1, 2023, and October 1, 2025, will be included. Data will be obtained from hospital information systems and anesthesia records
Primary Outcome
The aim of this study was to evaluate the effect of red blood cell and whole blood storage duration on 28-day mortality in severely injured trauma patients (injury severity score \>15) undergoing massive transfusion.
Conditions Studied
Study Locations (1)
Florida
- UF Health Jacksonville (Shands Hospital) - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2026-01-17 |
| Est. Completion | 2026-06-01 |
What NCT07341139 shows while recruiting
NCT07341139 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 3 conditions, with Transfusion Adverse Reaction appearing as the primary indexed condition, and to 0 interventions.
NCT07341139 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07341139 about?
NCT07341139 is a clinical study titled "Blood Storage Related Mortality and Adverse Effects in Trauma Patients". The purpose of this retrospective study is to examine the following factors related to blood storage time in severely injured trauma patients who received large blood transfusions: 1. The effect of blood storage time on the patient's 28-day mortality rate. 2. The relationship between storage time a...
What is the current status of trial NCT07341139?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2026-01-17. Estimated completion is 2026-06-01.
What conditions does trial NCT07341139 study?
This clinical trial studies the following conditions: Transfusion Adverse Reaction, Major Trauma, Blood Product Transfusion for All Conditions.
Who is sponsoring clinical trial NCT07341139?
This trial is sponsored by Kocaeli City Hospital, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07341139 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI